NEUVOGEN THERAPEUTICS
Live / Allowed — Third extension granted (statement of use) (as of 31 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Apr 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98516970
- Mark type
- Word mark
- Filed
- 24 Apr 2024
- Published for opposition
- 10 Dec 2024
- Attorney of record
- Bret J. Danow
Goods and services
- Class 005 — Pharmaceuticals: Vaccines
Owner
- Neuvogen, Inc., San Diego, CA, US
- Neuvogen, Inc., San Diego, CA, US
Prosecution history
- 01 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2026 — SOU EXTENSION 3 GRANTED
- 28 Jul 2026 — SOU EXTENSION 3 FILED
- 28 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2025 — CORRECTED NOA E-MAILED
- 31 Dec 2025 — SOU EXTENSION 2 GRANTED
- 17 Aug 2025 — SOU EXTENSION 2 FILED
- 31 Dec 2025 — DIVISIONAL PROCESSING COMPLETE
- 18 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 30 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jul 2025 — SOU EXTENSION 1 GRANTED